These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10784620)

  • 1. Oligonucleotide therapeutics: a step forward.
    Gewirtz AM
    J Clin Oncol; 2000 May; 18(9):1809-11. PubMed ID: 10784620
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of specific oligonucleotides in clinical medicine and their use in the treatment of patients with infective diseases].
    Bojić I
    Vojnosanit Pregl; 1996; 53(5):399-408. PubMed ID: 9229959
    [No Abstract]   [Full Text] [Related]  

  • 3. Antisense oligonucleotide technology in the development of cancer therapeutics.
    Tseng BY; Brown KD
    Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent progress and prospect in oligonucleotide therapeutics].
    Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
    Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of antisense oligonucleotides as anti-cancer therapeutics.
    Chen HX
    Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768
    [No Abstract]   [Full Text] [Related]  

  • 6. Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?
    Loriot Y; Mordant P; Deutsch E
    Ann Oncol; 2009 Mar; 20(3):596-7; author reply 597. PubMed ID: 19164457
    [No Abstract]   [Full Text] [Related]  

  • 7. Antisense oligonucleotides and the rational design of new antitumor drugs.
    Prieto J; Hernández-Alcoceba R
    Rev Esp Enferm Dig; 2005 Jul; 97(7):467-71. PubMed ID: 16262525
    [No Abstract]   [Full Text] [Related]  

  • 8. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 9. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of antisense technology in ophthalmology].
    Guo Y; Ge J
    Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides in cancer.
    Castanotto D; Stein CA
    Curr Opin Oncol; 2014 Nov; 26(6):584-9. PubMed ID: 25188471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Computer aid design of antisense oligonucleotide in gene therapy--review].
    Wu QW; Wu JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):387-91. PubMed ID: 15228675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal protein P2: a potential molecular target for antisense therapy of human malignancies.
    Gardner-Thorpe J; Ito H; Ashley SW; Whang EE
    Anticancer Res; 2003; 23(6C):4549-60. PubMed ID: 14981896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense therapeutics in oncology: points to consider in their clinical evaluation.
    Mani S; Gu Y; Wadler S; Fingert H
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):543-7. PubMed ID: 10645781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Message therapy: gene therapy that targets mRNA sequence and stability.
    Kozarsky KF; Couture LA
    Am J Hum Genet; 1997 Oct; 61(4):790-4. PubMed ID: 9382086
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNAs and their antagonists as novel therapeutics.
    Shomron N
    Eur J Cancer; 2009 Sep; 45 Suppl 1():388-90. PubMed ID: 19775642
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular approaches to cancer therapy.
    Israel MA
    Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.